About
AI-based drug screening platform for age-related therapies
Areas of Focus
Categories
AI FocusedBiotech
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
5,060
By Phase
PHASE2: 1
By Status
UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
Hover over trial bars to see details
Recent Trials
NCT00313495Lead Sponsor
Cooperative Huntington's Observational Research Trial
N/AUnknown
5,000 participants
Started: Feb 28, 2006 · Completed: Dec 31, 2020
NCT00212316Collaborator
Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)
PHASE2Completed
60 participants
Started: Aug 31, 2005 · Completed: Jun 30, 2006
Locations (1)
Headquarters
South SF, CA, United States
Map
Loading map...